Get the Stockscreener App
4.50
0.66%
-0.03
Tilray Brands Inc stock is traded at $4.50, with a volume of 2.74M.
It is down -0.66% in the last 24 hours and down -3.02% over the past month.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
See More
Previous Close:
$4.53
Open:
$4.51
24h Volume:
2.74M
Relative Volume:
0.69
Market Cap:
$619.11M
Revenue:
$858.28M
Net Income/Loss:
$-1.34B
P/E Ratio:
-0.3294
EPS:
-13.6608
Net Cash Flow:
$-75.96M
1W Performance:
-1.96%
1M Performance:
-3.02%
6M Performance:
-38.36%
1Y Performance:
-60.87%
1-Day Range:
$4.45
$4.54
1-Week Range:
$4.44
$4.6801
52-Week Range:
$3.67
$23.20
Tilray Brands Inc Stock (TLRY) Company Profile
Name
Tilray Brands Inc
Sector
Phone
519.322.8800
Address
655 MADISON AVENUE, NEW YORK
Compare TLRY vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
4.50 | 642.50M | 858.28M | -1.34B | -75.96M | -13.66 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-02-26 | Upgrade | Roth Capital | Neutral → Buy |
| Jan-27-26 | Initiated | Canaccord Genuity | Hold |
| Apr-05-24 | Reiterated | Alliance Global Partners | Neutral |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-29-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Mar-04-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-18-21 | Initiated | Barclays | Underweight |
| Nov-01-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-11-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-03-21 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| May-11-21 | Resumed | Cowen | Outperform |
| May-07-21 | Resumed | Jefferies | Buy |
| May-06-21 | Initiated | Canaccord Genuity | Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-18-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-18-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-01-20 | Reiterated | MKM Partners | Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| May-12-20 | Reiterated | The Benchmark Company | Buy |
| Apr-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Apr-09-20 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-13-20 | Initiated | BofA/Merrill | Neutral |
| Nov-13-19 | Reiterated | The Benchmark Company | Buy |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-22-19 | Reiterated | Piper Jaffray | Overweight |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Aug-14-19 | Reiterated | The Benchmark Company | Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Neutral |
| Jun-28-19 | Initiated | Consumer Edge Research | Overweight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Initiated | Oppenheimer | Perform |
| May-15-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-13-19 | Initiated | Alliance Global Partners | Neutral |
View All
Tilray Brands Inc Stock (TLRY) Latest News
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here’s Why TLRY Is Still Down 47% YTD - AOL.com
Tilray Brands (NASDAQ:TLRY) Shares Up 3.6%Here's What Happened - MarketBeat
Tilray Brands Inc. stock rises Friday, outperforms market - MarketWatch
Canadian LPs expand presence in European cannabis as demand grows - MJBizDaily
Tilray Brands (NASDAQ:TLRY) Strategy Shift Shapes Cannabis Trends - Kalkine Media
Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell? - The Globe and Mail
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. - AOL.com
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. - The Motley Fool
Why Does Tilray Brands (NASDAQ:TLRY) Face a New Cash Flow Test? - Kalkine Media
Tilray Keeps Closing Craft Breweries Because Its Strategy Never Made Sense in the First Place - VinePair
Tilray Expands Cannabis Cultivation Capacity in Canada, Europe to Meet International Demand - Cannabis Business Times
Tilray Brands (NASDAQ:TLRY) Shares Down 3.3%Should You Sell? - MarketBeat
Tilray Brands Inc. stock falls Thursday, underperforms market - MarketWatch
Tilray Brands (NASDAQ:TLRY): Business Updates Under Review - Kalkine Media
Tilray (TLRY) Results Versus Estimates: EPS Falls Short of Its Estimate for This Review; Market Move: Shares Finish 5.18% Down on the DayGAAP Earnings Report - Vinanet
Small caps to watch: Roots announces go-private deal, along with updates from Questerre Energy, Tilray and Aurora - The Globe and Mail
Stocks in play: Tilray Brands Inc. - The Globe and Mail
Tilray Brands Inc. - Baystreet.ca
Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way? - AOL.com
TLRY Looks 58.9% Undervalued on GF Value™ Amid Capacity Expansio - GuruFocus
Tilray Expands Global Cannabis Production Capacity to 275 Metric Tonnes - marketscreener.com
Tilray lifts annual cannabis cultivation capacity to about 275 metric tonnes (TLRY:NASDAQ) - Seeking Alpha
Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand - marketscreener.com
What Should Markets Watch at Tilray Brands (NASDAQ:TLRY) Now? - Kalkine Media
Tilray Brands (NASDAQ:TLRY) Stock Price Up 8.1%Should You Buy? - MarketBeat
Tilray Brands Inc. stock rises Wednesday, outperforms market - MarketWatch
Tilray (TLRY) Results Check: Reported EPS Misses Expectations in the Current Update; Share Response - Vinanet
Tilray Brands (NASDAQ:TLRY): The Cannabis Story Is Getting Complicated - Kalkine Media
Could Tilray Brands (NASDAQ:TLRY) Gain From Its UK Push? - Kalkine Media
Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development - Sahm
Tilray (TLRY) Results and Estimates: The Available Earnings Metric Delivers a Miss in the Current Update; Market Reaction: Shares Fall 0.22%Earnings Revision Downgrade - Vinanet
Tilray Brands (NASDAQ: TLRY): Key Catalysts Come Into Focus - Kalkine Media
Tilray Brands (NASDAQ:TLRY): What Could Shift the Story? - Kalkine Media
BrewDog Unwraps Its 2026 Advent Calendar - markets.businessinsider.com
BrewDog's Christmas box packs 24 beers and a glass made for this year's edition - Stock Titan
Tilray Medical Welcomes Progress in Germany’s Medical - GlobeNewswire
Why Is Tilray Brands (NASDAQ:TLRY) in Focus as Rescheduling Hopes Reshape the Cannabis Mood? - Kalkine Media
Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Shares Down 4.1%Here's What Happened - MarketBeat
Tilray Medical Accelerates Commercial Expansion in UK With Direct-to-Patient Launch - Cannabis Business Times
Tilray Brands Inc. stock falls Monday, underperforms market - MarketWatch
Why Is Tilray Brands (TSX:TLRY) Making Headlines Among Cannabis Stocks? - Kalkine Media
Tilray Brands (NASDAQ:TLRY) Shares Draw Attention Amid Global Expansion Push - Kalkine Media
Tilray Brands, Inc. - Baystreet.ca
Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub - markets.businessinsider.com
An 800-square-foot brewpub opens on Long Island’s North Shore—who’s behind it? - Stock Titan
Weekly Recap: Beverage int'l sales and Hi*Ball energy partnership - TradingView
Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary - The Globe and Mail
A new UK route for medical cannabis patients runs through Lyphe - Stock Titan
Tilray Brands (NASDAQ:TLRY): Why Is Diversified Platform in Focus Today? - Kalkine Media
Tilray Brands (NASDAQ:TLRY) stock in focus as cannabis beverage launch draws attention - Kalkine Media
Tilray Brands Inc Stock (TLRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tilray Brands Inc Stock (TLRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Merton Carl A | Chief Financial Officer |
Aug 26 '26 |
Option Exercise |
0.00 |
168,452 |
0 |
276,646 |
| Gendel Mitchell | Global General Counsel |
Aug 26 '26 |
Option Exercise |
0.00 |
160,304 |
0 |
258,392 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Aug 26 '26 |
Option Exercise |
0.00 |
178,221 |
0 |
288,657 |
| Gendel Mitchell | Global General Counsel |
Aug 06 '26 |
Buy |
4.43 |
2,500 |
11,075 |
124,883 |
| Merton Carl A | Chief Financial Officer |
Aug 04 '26 |
Buy |
4.62 |
10,000 |
46,200 |
139,753 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Aug 03 '26 |
Buy |
4.78 |
2,500 |
11,950 |
141,285 |
| SIMON IRWIN D | President and CEO |
Jul 30 '26 |
Option Exercise |
0.00 |
117,647 |
0 |
801,666 |
| SIMON IRWIN D | President and CEO |
Jul 29 '26 |
Option Exercise |
0.00 |
428,448 |
0 |
911,097 |
| Merton Carl A | Chief Financial Officer |
Jul 30 '26 |
Option Exercise |
0.00 |
16,656 |
0 |
138,914 |
| Merton Carl A | Chief Financial Officer |
Jul 29 '26 |
Option Exercise |
0.00 |
60,417 |
0 |
152,467 |
1.66%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):